| 4/28/2014 | BKHYPF | S&P lowers Vantage Oncology
|
| 10/31/2013 | BKHYPF | S&P: Vantage Oncology unchanged after add-on
|
| 5/21/2013 | BKHY | Moody's rates Vantage notes B2
|
| 5/20/2013 | BK | Vantage Oncology to repay loan borrowings with notes proceeds
|
| 5/20/2013 | BKHY | S&P assigns B to Vantage Oncology notes
|
| 3/24/2011 | BK | S&P rates Vantage B, Physician Oncology loan B
|
| 2/28/2011 | BK | Market Commentary: Texas Competitive trades up with alleged default; Visant, Vantage Oncology, Playboy break
|
| 2/22/2011 | BK | Market Commentary: Michael Foods, Kalispel break; Vantage, Affordable, Serena, Carestream, Cedar tweak deals
|
| 2/22/2011 | BK | Vantage Oncology cuts pricing on term B, adds $25 million delayed draw
|
| 2/10/2011 | BK | Vantage Oncology launches $221 million term B at Libor plus 525 bps
|
| 2/10/2011 | BK | S&P: Physician Oncology, loan B
|
| 2/10/2011 | BK | Market Commentary: Gymboree tweaks deal, levels rise; Reynolds, Affinion, Oriental Trading, Sedgwick break
|
| 2/1/2011 | BK | Market Commentary: Gymboree dips; National Surgical, IWCO break; GEO sets spread; Summit, AccentCare reveal talk
|
| 2/1/2011 | BK | Vantage Oncology to launch $246 million credit facility on Feb. 10
|
| 7/11/2008 | BK | Vantage Oncology obtains $100 million term loan through Ares Capital
|
